We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Events

26 Oct 2026 - 29 Oct 2026
16 Nov 2026 - 19 Nov 2026

Antibiotic Resistance Genes Found in Newborns Within Hours of Birth

By HospiMedica International staff writers
Posted on 23 Apr 2026

Antibiotic resistance in early life is challenging to characterize, particularly around the timing and drivers of gene acquisition in newborns. More...

Meconium, the first stool passed by infants, was long considered sterile, yet recent molecular studies have detected microbial genetic material in these samples. Early microbial exposure has also been proposed as a contributor to resistance development. Researchers now present data showing that multiple antibiotic resistance genes can be detected in newborns within hours of birth.

Aristotle University of Thessaloniki led a multidisciplinary study that screened meconium collected from 105 infants admitted to a neonatal intensive care unit (NICU) within the first 72 hours of life. Conducted between July 2024 and July 2025, the analysis targeted 56 resistance genes associated with commonly used antibiotics. The work was presented at ESCMID Global 2026.

The approach focused on identifying antibiotic resistance genes (ARGs)—segments of DNA that enable bacteria to withstand antimicrobial treatment—and characterizing their early presence in the neonatal gut. Prior findings referenced by the investigators indicate that meconium can harbor microbial genetic material, suggesting exposure may occur during pregnancy. The team notes that ARG carriage at this stage may facilitate dissemination through horizontal gene transfer among bacteria, underscoring the relevance of early-life resistome profiling.

Results showed a high prevalence of specific ARGs. The oqxA gene was detected in 98% of samples and qnrS in 96%. Genes encoding beta-lactamases, enzymes that degrade widely used beta-lactam antibiotics, were also frequent, including blaCTXM (55%), blaCMY (51%), and blaSHV (39%). Genes associated with carbapenem resistance—a last-line antibiotic class—were present in 21% of samples. Each meconium specimen contained a median of eight resistance genes.

Analyses further linked ARG detection with maternal and early neonatal factors. Presence of the msrA gene, which confers macrolide-streptogramin resistance, was associated with maternal hospitalization during pregnancy. A higher total number of ARGs correlated with central venous catheter placement within 24 hours of life, while resuscitation shortly after birth was unexpectedly associated with fewer ARGs, a finding the team advises interpreting cautiously. Overall, the investigators conclude that both maternal transmission and early hospital exposures may contribute to establishing ARGs in the neonatal gut and emphasize the importance of surveillance and infection prevention and control in neonatal care.

"This finding suggests that a pattern of ARGs is already established at this stage. The neonatal gut harbors a diverse resistome, and the presence of clinically important ARGs so early in life is concerning," said lead author Dr. Argyro Ftergioti. "Although some ARGs were expected, their high prevalence across the majority of samples was striking—particularly for clinically critical genes offering carbapenem resistance."

Related Links
ESCMID Global


Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Hybrid Arch Device
Neo EDE
Surgical System
Stealth AXiS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Half-matched bone marrow transplant expands access to curative treatment for children and young adults with severe aplastic anemia. (Photo courtes of Margarita Dionysiou using Bio Render)

Half-Matched Family Donors Could Expand Transplant Access for Severe Aplastic Anemia

Severe aplastic anemia is a rare, life-threatening disorder in which the bone marrow fails to produce enough healthy blood cells, leaving children and young adults vulnerable to anemia, infection, and bleeding.... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.